Skip to main content
Clinical Trials/CTRI/2024/04/065793
CTRI/2024/04/065793
Not yet recruiting
Phase 2

A Single Arm clinical study to evaluate the efficacy of Darvyadi Kwath in Diabetic Polyneuropathy. - nil

Dr Swapnil Balasaheb Kedar0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Swapnil Balasaheb Kedar
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Swapnil Balasaheb Kedar

Eligibility Criteria

Inclusion Criteria

  • A known Diabetic on treatment.
  • Patient who are not taking any medications for Diabetic Polyneuropathy And having symptoms of Diabetic Polyneuropathy

Exclusion Criteria

  • 1\.Pregnant lactating women.
  • 2\.Patients with pulmonary tuberculosis, cardiac complications, Renal complications, sciatica, cord compression, Immunocompromised patients, malignancies.
  • 3\.Vitamin B12 deficiency.

Outcomes

Primary Outcomes

Not specified

Similar Trials